scorecardresearch
Serum Institute urges govt to fast-track movement of its COVID-19 vaccine Covishield

Serum Institute urges govt to fast-track movement of its COVID-19 vaccine Covishield

Serum Institute of India cited the difficulties being faced in production and cold chain space planning for other vaccines because of the increasing stock of its COVID-19 jab.

Serum Institute will commence its Covid vaccine export under the COVAX programme from November 23. Serum Institute will commence its Covid vaccine export under the COVAX programme from November 23.

Serum Institute of India (SII) has urged the government to fast-track Covishield movement citing the difficulties being faced in production and cold chain space planning for other vaccines because of the increasing stock of its COVID-19 jab, official sources said on Sunday.

Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, is learnt to have recently communicated to the Union Health Ministry that it has a manufactured stock of 24,89,15,000 Covishield doses and it is increasing every day.

In addition to the Covishield vaccine, the Pune-based firm also manufactures and supplies various life-saving vaccines to EPI, UNICEF and different countries, Singh is learnt to have told the ministry.

"To fulfil our domestic and global supply commitments, we have to plan our production/cold chain space/human resource well in advance. In view of continuous increase in the stock of Covishield, we are facing a lot of difficulties in production/cold chain space/human resource planning for other life-saving vaccines," an official source quoted Singh as having stated in the letter.

Also Read: Extended suspension of international flights impacting financial health of airlines: Vistara

"In view of these facts, genuine difficulties and as this matter is directly concerned with the availability of various other life-saving vaccines in our country and the world at large, we request for your kind intervention for fast-track movement of our Covishield vaccine domestically and globally," Singh is learnt to have stated.

The Centre has allowed SII to export 50 lakh doses of Covishield under the UN-backed COVAX global vaccine sharing programme to Nepal, Tajikistan and Mozambique. SII will also export Covishield to Bangladesh under COVAX, an official source said.

The Serum Institute will commence its Covid vaccine export under the COVAX programme from November 23 and Nepal will receive the first lot of Covishiled on November 24.

The government had in October permitted SII to export 10 lakh Covishield doses, each to Nepal, Myanmar and Bangladesh under the 'Vaccine Maitri' programme.

Also Read: Govt to outdo FY22 tax collection; direct tax collection at Rs 6 lakh cr till Oct, says Revenue Secy

Published on: Nov 21, 2021, 7:55 PM IST
Posted by: Vinay Rai, Nov 21, 2021, 7:47 PM IST